Free Trial

Arecor Therapeutics (AREC) Competitors

Arecor Therapeutics logo
GBX 48.12 -0.88 (-1.79%)
As of 07/16/2025 06:48 AM Eastern

AREC vs. ORPH, REDX, ETX, SBTX, COS, C4XD, DDDD, SAR, TRX, and FUM

Should you be buying Arecor Therapeutics stock or one of its competitors? The main competitors of Arecor Therapeutics include Open Orphan (ORPH), Redx Pharma (REDX), e-therapeutics (ETX), SkinBioTherapeutics (SBTX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Sareum (SAR), Tissue Regenix Group (TRX), and Futura Medical (FUM). These companies are all part of the "biotechnology" industry.

Arecor Therapeutics vs. Its Competitors

Open Orphan (LON:ORPH) and Arecor Therapeutics (LON:AREC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

44.1% of Arecor Therapeutics shares are held by institutional investors. 25.3% of Arecor Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Open Orphan has a net margin of 0.00% compared to Arecor Therapeutics' net margin of -176.89%. Open Orphan's return on equity of 0.00% beat Arecor Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Open OrphanN/A N/A N/A
Arecor Therapeutics -176.89%-118.67%-37.31%

In the previous week, Open Orphan had 1 more articles in the media than Arecor Therapeutics. MarketBeat recorded 1 mentions for Open Orphan and 0 mentions for Arecor Therapeutics. Open Orphan's average media sentiment score of 0.00 equaled Arecor Therapeutics'average media sentiment score.

Company Overall Sentiment
Open Orphan Neutral
Arecor Therapeutics Neutral

Open Orphan has higher revenue and earnings than Arecor Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Open Orphan£34.71M0.00N/AN/AN/A
Arecor Therapeutics£6.04M3.01-£10.68M-£28.30-1.70

Summary

Open Orphan beats Arecor Therapeutics on 5 of the 8 factors compared between the two stocks.

Get Arecor Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for AREC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AREC vs. The Competition

MetricArecor TherapeuticsBiotechnology IndustryMedical SectorLON Exchange
Market Cap£18.17M£131.03M£5.51B£3.01B
Dividend YieldN/A3.74%4.25%5.02%
P/E Ratio-1.703.6028.12166.90
Price / Sales3.014,246.15439.46318,946.57
Price / Cash5.0713.1935.5327.97
Price / Book2.9042.108.234.61
Net Income-£10.68M-£92.15M£3.23B£5.90B
7 Day Performance-0.58%0.57%-0.52%2.47%
1 Month Performance13.23%4.60%6.71%8.85%
1 Year Performance-49.35%163.33%27.10%64.49%

Arecor Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AREC
Arecor Therapeutics
N/AGBX 48.12
-1.8%
N/A-50.4%£18.17M£6.04M-1.7010
ORPH
Open Orphan
N/AN/AN/AN/A£67.09M£34.71M-25.30179News Coverage
REDX
Redx Pharma
N/AN/AN/AN/A£58.35M£4.20M-150.00101Gap Up
High Trading Volume
ETX
e-therapeutics
N/AN/AN/AN/A£52.59M£295K-450.0035High Trading Volume
SBTX
SkinBioTherapeutics
N/AGBX 16.63
+0.8%
N/A+84.7%£37.98M£1.56M-10.2311
COS
Collagen Solutions plc (COS.L)
N/AN/AN/AN/A£30.99M£4.01M-8.283,350
C4XD
C4X Discovery
N/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AN/AN/AN/A£30.05M£718K-1.08106
SAR
Sareum
N/AGBX 21
+6.3%
N/A-48.7%£26.24MN/A-4.973,211
TRX
Tissue Regenix Group
N/AGBX 28.50
flat
N/A-60.9%£25.69M£31.98M-29.42120Gap Up
FUM
Futura Medical
N/AGBX 7.85
+5.4%
N/A-72.2%£24.47M£8.68M-6.4812Gap Down

Related Companies and Tools


This page (LON:AREC) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners